Clinical impact of SGLT2 inhibitor after DC cardioversion in persistent atrial fibrillation patients with heart failure with preserved ejection fractio
Not Applicable
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0009157
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
? Patients aged 19 or more
? Patients with persistent atrial fibrillation
? H2FPEF diagnostic criteria of 6 or more or HFA-PEFF diagnostic criteria of 5 or more
? Patients who have converted to sinus rhythm after DC cardioversion
Exclusion Criteria
? Patients who used SGLT2 inhibitors in the past
? Patients with less than 45 creatinine clearance
? Patients with intracardiac thrombus confirmed by transesophageal echocardiography
? Patients who refused to participate in the study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method